Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
211 Leser
Artikel bewerten:
(1)

The Exterior Company, LLC: The Exterior Company Restores Historic Marietta Home With Free Roof Through Under One Roof Giveaway

Finanznachrichten News

MARIETTA, PA / ACCESSWIRE / December 4, 2024 / The Exterior Company (TEC) is proud to announce the latest recipient of its Under One Roof program: Ian and Caitlyn Clayton, the dedicated stewards of the historic Sultzbach-Reinhart House. Built in 1812, this Marietta landmark represents more than just history-it's the heart of a young family's dream to create a forever home.

The Clayton family purchased the property just over a year ago, embracing its character and history while committing to restoring it for future generations. Like any historic home, it comes with its share of challenges. But for Ian, an Army veteran medically discharged after a severe back injury, and Caitlyn, those challenges were worth it as they worked tirelessly to make their dream home a reality.

When the Claytons reached out to TEC, they were hoping for assistance with their aging roof. But as Project Manager Melvin Kleinsasser discovered, their story was about more than just shingles and gutters.

"When I first met the Clayton family, I could tell this was more than a project-this was an opportunity to make a real impact," said Kleinsasser. "This home is a perfect fit for our Under One Roof program. It's not just about restoring a historic icon; it's about helping a family that truly deserves it."

Ian has taken on several jobs to support his family and their vision of turning the Sultzbach-Reinhart House into their forever home. Despite the challenges, including his injury, he continues to provide for his family and remains deeply committed to his community in Marietta.

Receiving a new roof was an emotional milestone for the Claytons.

"We are overwhelmed with gratitude and feel like a huge burden has been lifted," shared Ian and Caitlyn. "This gift is so much more than a roof-it's peace of mind, safety, and hope for the future. We can't thank TEC enough."

TEC's Under One Roof program underscores its mission to give back. For every 1,000 roofs installed, the company donates a free roof to a deserving homeowner. This initiative is made possible through partnerships with industry leaders like Atlas Roofing, which generously donated materials for this project.

"This program is about more than just roofs," explained TEC Chief Operating Officer Joe Hydrick. "It's about restoring hope and giving families the ability to focus on building their futures. For the Clayton family, and for the Sultzbach-Reinhart House, this is a way to honor the past while creating a solid foundation for years to come."

TEC's dedication to community and craftsmanship is evident in every project. The restored roof not only protects the Clayton family but also preserves a vital piece of Marietta's history.

Contact Information

TEC Marketing
marketing@tecroofs.com
717-312-7788

Related Images

Under One Roof 2024 - Marietta, PA

Under One Roof 2024 - Marietta, PA

The Historic Sultzbach-Reinhart House

The Historic Sultzbach-Reinhart House

The Clayton Family

The Clayton Family

SOURCE: The Exterior Company, LLC



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.